Sloan Kettering Researchers Correct the Record by Revealing Company Ties

The revised conflict-of-interest disclosures include new information about financial ties between top cancer researchers and for-profit companies. CHARLES ORNSTEIN and KATIE THOMAS https://ift.tt/2OTtAZz https://ift.tt/2yE6lbE The New York Times Health Research, Drugs (Pharmaceuticals), Boards of Directors October 12, 2018 at 12:00AM